Hematology Drugs Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：125頁
文件格式：PDF
價 格：
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
Increase in number of Hematology disease drug approvals from the regulatory bodies such as FDA in the US and EMA in EU is an emerging trend in the market. For instance, in June 2017, Novo Nordisk received FDA approval for its Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) that is used in the treatment of hemophilia B.
The Hematology Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global hematology drugs sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the hematology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hematology drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The hematology drugs market section of the report gives context. It compares the hematology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Hematology Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs
Companies Mentioned: Baxalta, Bayer AG, Novo Nordisk, Pfizer Inc., and Biogen Idec
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Hematology Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
The Hematology Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global hematology drugs sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the hematology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hematology drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The hematology drugs market section of the report gives context. It compares the hematology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Hematology Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs
Companies Mentioned: Baxalta, Bayer AG, Novo Nordisk, Pfizer Inc., and Biogen Idec
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Hematology Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Hematology Drugs Market Characteristics;
2. Hematology Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Hematology Drugs Market Customer Information;
5. Hematology Drugs Market Segmentation;
5.1. Global Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 5.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Hematology Drugs Market Trends And Strategies;
6. Hematology Drugs Market Regional And Country Analysis;
6.1. Global Hematology Drugs Market, 2016, By Region; 6.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Hematology Drugs Market, 2016, By Country; 6.4. Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Hematology Drugs Market Comparison With Macro Economic Factors;
7.1. Hematology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Hematology Drugs Expenditure, Global;
8. Hematology Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Hematology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Hematology Drugs Expenditure, By Country;
9. Hematology Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Hematology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Hematology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Hematology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Hematology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Thalassemia, 2014, By Country;
10. Asia-Pacific Hematology Drugs Market;
10.1.1. Asia-Pacific Hematology Drugs Market Overview; 10.1.2. Asia-Pacific Hematology Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Hematology Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.2. Asia-Pacific Hematology Drugs Market: Country Analysis; 10.3. China Hematology Drugs Market; 10.3.1. China Hematology Drugs Market Overview; 10.3.2. China Hematology Drugs Historic Market, 2012 - 2016; 10.3.3. China Hematology Drugs Forecast Market, 2016 - 2020; 10.3.4. China Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.3.5. China Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.4. India Hematology Drugs Market; 10.4.1. India Hematology Drugs Market Overview; 10.4.2. India Hematology Drugs Historic Market, 2012 - 2016; 10.4.3. India Hematology Drugs Forecast Market, 2016 - 2020; 10.4.4. India Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.4.5. India Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.5. Japan Hematology Drugs Market; 10.5.1. Japan Hematology Drugs Market Overview; 10.5.2. Japan Hematology Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Hematology Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.5.5. Japan Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.6. Australia Hematology Drugs Market; 10.6.1. Australia Hematology Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Hematology Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.6.4. Australia Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
11. Western Europe Hematology Drugs Market;
11.1.1. Western Europe Hematology Drugs Market Overview; 11.1.2. Western Europe Hematology Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Hematology Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.2. Western Europe Hematology Drugs Market: Country Analysis; 11.3. UK Hematology Drugs Market; 11.3.1. UK Hematology Drugs Market Overview; 11.3.2. UK Hematology Drugs Historic Market, 2012 - 2016; 11.3.3. UK Hematology Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.3.5. UK Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.4. Germany Hematology Drugs Market; 11.4.1. Germany Hematology Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Hematology Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.4.4 Germany Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.5 France Hematology Drugs Market; 11.5.1 France Hematology Drugs Historic Market, 2012 - 2016; 11.5.2 France Hematology Drugs Forecast Market, 2016 - 2020; 11.5.3 France Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.5.4 France Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.6. Italy Hematology Drugs Market; 11.6.1. Italy Hematology Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Hematology Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.6.4. Italy Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.7. Spain Hematology Drugs Market; 11.7.1. Spain Hematology Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Hematology Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.7.4. Spain Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Hematology Drugs Market;
12.1.1. Eastern Europe Hematology Drugs Market Overview; 12.1.2. Eastern Europe Hematology Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Hematology Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.2. Eastern Europe Hematology Drugs Market: Country Analysis; 12.3. Russia Hematology Drugs Market; 12.3.1. Russia Hematology Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Hematology Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.3.4. Russia Hematology Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
13. North America Hematology Drugs Market;
13.1.1. North America Hematology Drugs Market Overview; 13.1.2. North America Hematology Drugs Historic Market, 2012 - 2016; 13.1.3. North America Hematology Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.2. North America Hematology Drugs Market: Country Analysis; 13.3. USA Hematology Drugs Market; 13.3.1. USA Hematology Drugs Historic Market, 2012 - 2016; 13.3.2. USA Hematology Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.3.4. USA Hematology Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
14. South America Hematology Drugs Market;
14.1.1. South America Hematology Drugs Market Overview; 14.1.2. South America Hematology Drugs Historic Market, 2012 - 2016; 14.1.3. South America Hematology Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.2. South America Hematology Drugs Market: Country Analysis; 14.3. Brazil Hematology Drugs Market; 14.3. Brazil Hematology Drugs Market; 14.3.1. Brazil Hematology Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Hematology Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.3.4. Brazil Hematology Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
15. Middle East Hematology Drugs Market;
15.1.1. Middle East Hematology Drugs Market Overview; 15.1.2. Middle East Hematology Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Hematology Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
16. Africa Hematology Drugs Market;
16.1.1. Africa Hematology Drugs Market Overview; 16.1.2. Africa Hematology Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Hematology Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
17. Hematology Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Baxalta; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Bayer Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Novo Nordisk; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Biogen Idec; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Hematology Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Hematology Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Hematology Drugs Market Customer Information;
5. Hematology Drugs Market Segmentation;
5.1. Global Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 5.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Hematology Drugs Market Trends And Strategies;
6. Hematology Drugs Market Regional And Country Analysis;
6.1. Global Hematology Drugs Market, 2016, By Region; 6.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Hematology Drugs Market, 2016, By Country; 6.4. Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Hematology Drugs Market Comparison With Macro Economic Factors;
7.1. Hematology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Hematology Drugs Expenditure, Global;
8. Hematology Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Hematology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Hematology Drugs Expenditure, By Country;
9. Hematology Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Hematology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Hematology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Hematology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Hematology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Thalassemia, 2014, By Country;
10. Asia-Pacific Hematology Drugs Market;
10.1.1. Asia-Pacific Hematology Drugs Market Overview; 10.1.2. Asia-Pacific Hematology Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Hematology Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.2. Asia-Pacific Hematology Drugs Market: Country Analysis; 10.3. China Hematology Drugs Market; 10.3.1. China Hematology Drugs Market Overview; 10.3.2. China Hematology Drugs Historic Market, 2012 - 2016; 10.3.3. China Hematology Drugs Forecast Market, 2016 - 2020; 10.3.4. China Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.3.5. China Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.4. India Hematology Drugs Market; 10.4.1. India Hematology Drugs Market Overview; 10.4.2. India Hematology Drugs Historic Market, 2012 - 2016; 10.4.3. India Hematology Drugs Forecast Market, 2016 - 2020; 10.4.4. India Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.4.5. India Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.5. Japan Hematology Drugs Market; 10.5.1. Japan Hematology Drugs Market Overview; 10.5.2. Japan Hematology Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Hematology Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.5.5. Japan Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.6. Australia Hematology Drugs Market; 10.6.1. Australia Hematology Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Hematology Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.6.4. Australia Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
11. Western Europe Hematology Drugs Market;
11.1.1. Western Europe Hematology Drugs Market Overview; 11.1.2. Western Europe Hematology Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Hematology Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.2. Western Europe Hematology Drugs Market: Country Analysis; 11.3. UK Hematology Drugs Market; 11.3.1. UK Hematology Drugs Market Overview; 11.3.2. UK Hematology Drugs Historic Market, 2012 - 2016; 11.3.3. UK Hematology Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.3.5. UK Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.4. Germany Hematology Drugs Market; 11.4.1. Germany Hematology Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Hematology Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.4.4 Germany Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.5 France Hematology Drugs Market; 11.5.1 France Hematology Drugs Historic Market, 2012 - 2016; 11.5.2 France Hematology Drugs Forecast Market, 2016 - 2020; 11.5.3 France Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.5.4 France Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.6. Italy Hematology Drugs Market; 11.6.1. Italy Hematology Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Hematology Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.6.4. Italy Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.7. Spain Hematology Drugs Market; 11.7.1. Spain Hematology Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Hematology Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.7.4. Spain Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Hematology Drugs Market;
12.1.1. Eastern Europe Hematology Drugs Market Overview; 12.1.2. Eastern Europe Hematology Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Hematology Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.2. Eastern Europe Hematology Drugs Market: Country Analysis; 12.3. Russia Hematology Drugs Market; 12.3.1. Russia Hematology Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Hematology Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.3.4. Russia Hematology Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
13. North America Hematology Drugs Market;
13.1.1. North America Hematology Drugs Market Overview; 13.1.2. North America Hematology Drugs Historic Market, 2012 - 2016; 13.1.3. North America Hematology Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.2. North America Hematology Drugs Market: Country Analysis; 13.3. USA Hematology Drugs Market; 13.3.1. USA Hematology Drugs Historic Market, 2012 - 2016; 13.3.2. USA Hematology Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.3.4. USA Hematology Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
14. South America Hematology Drugs Market;
14.1.1. South America Hematology Drugs Market Overview; 14.1.2. South America Hematology Drugs Historic Market, 2012 - 2016; 14.1.3. South America Hematology Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.2. South America Hematology Drugs Market: Country Analysis; 14.3. Brazil Hematology Drugs Market; 14.3. Brazil Hematology Drugs Market; 14.3.1. Brazil Hematology Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Hematology Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.3.4. Brazil Hematology Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
15. Middle East Hematology Drugs Market;
15.1.1. Middle East Hematology Drugs Market Overview; 15.1.2. Middle East Hematology Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Hematology Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
16. Africa Hematology Drugs Market;
16.1.1. Africa Hematology Drugs Market Overview; 16.1.2. Africa Hematology Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Hematology Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
17. Hematology Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Baxalta; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Bayer Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Novo Nordisk; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Biogen Idec; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Hematology Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
